Page last updated: 2024-08-17

tetrabenazine and Schizophrenia

tetrabenazine has been researched along with Schizophrenia in 31 studies

Research

Studies (31)

Timeframe	Studies, this research(%)	All Research%
pre-1990	10 (32.26)	18.7374
1990's	4 (12.90)	18.2507
2000's	5 (16.13)	29.6817
2010's	8 (25.81)	24.3611
2020's	4 (12.90)	2.80

Authors

Authors	Studies
Nomoto, M	1
Ito, H; Sakata, M	1
Kremens, DE; McEvoy, JP	1
Citrome, L; Saklad, SR	1
Burke, J; Factor, SA; Hauser, RA; Jimenez, R; Knesevich, MA; Liang, GS; Marder, SR; O'Brien, CF; Ramirez, PM	1
Burke, J; Correll, CU; Josiassen, RC; Liang, GS; O'Brien, CF	1
Burke, J; Josiassen, RC; Kane, JM; Liang, GS; O'Brien, CF	1
Burke, J; Correll, CU; Kane, JM; Liang, GS; O'Brien, CF	1
Correll, CU; Cutler, AJ; Kane, JM; Liang, GS; McEvoy, JP; O'Brien, CF	1
Correll, CU; Cutler, AJ; Kane, JM; Liang, GS; O'Brien, CF; Sajatovic, M; Stacy, M	1
Citrome, L	1
Agid, O; Borlido, C; Foussias, G; Javaid, N; Kapur, S; Mann, S; Remington, G; Richards, S	1
Rehavi, M; Valevski, A; Weizman, A; Zucker, M	1
ASHCROFT, GW; BARKER, PA; MACDOUGALL, EJ	1
HEINZE, H	1
SMITH, ME	1
LINGJAERDE, O	1
BOWERS, CA; HEUSLER, AF; QUICK, R; ULETT, GA; WORD, T; WORD, V	1
Balkoski, V; Malik, A	1
Isakov, V; Jabarin, M; Rauchverger, B	1
Inoue, M; Kato, M; Matsumoto, Y; Okagami, K; Totsuka, S	1
Goetz, CG; Klawans, HL	1
Fornazzari, L; Remington, G; Sethna, R	1
Goldman, M; Kalian, M; Lerner, V	1
Rittmannsberger, H; Silberbauer, C	1
Lloyd, J; Storey, E	1
Simpson, GM	1
Frey, KA; Koeppe, RA; Tandon, R; Taylor, SF; Zubieta, JK	1
Klerman, GL	1
Avrutskii, GIa; Mashkovskii, MD; Polezhaeva, AI; Smulevich, AB; Vertozgadova, OP	1

Reviews

3 review(s) available for tetrabenazine and Schizophrenia

Article	Year
Emerging pharmacological therapies in schizophrenia: what's new, what's different, what's next? CNS spectrums, 2016, Volume: 21, Issue:S1 Topics: Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Humans; Injections, Intramuscular; Paliperidone Palmitate; Piperazines; Quinolones; Schizophrenia; Tetrabenazine; Thiophenes; Valine	2016
The treatment of tardive dyskinesia and tardive dystonia. The Journal of clinical psychiatry, 2000, Volume: 61 Suppl 4 Topics: Adult; Akathisia, Drug-Induced; Algorithms; Antipsychotic Agents; Benzodiazepines; Clozapine; Decision Trees; Drug Administration Schedule; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Male; Olanzapine; Pirenzepine; Probability; Reserpine; Risperidone; Schizophrenia; Substance Withdrawal Syndrome; Tetrabenazine; Treatment Outcome; Vitamin E	2000
Pharmacotherapy of schizophrenia. Annual review of medicine, 1974, Volume: 25, Issue:0 Topics: Acridines; Administration, Oral; Antipsychotic Agents; Butyrophenones; Central Nervous System Diseases; Dopamine; Humans; Molindone; Phenothiazines; Phytotherapy; Piperazines; Plants, Medicinal; Rauwolfia; Schizophrenia; Seizures; Structure-Activity Relationship; Tetrabenazine; Thioxanthenes; Tranquilizing Agents; Vitamin B 12	1974

Trials

8 trial(s) available for tetrabenazine and Schizophrenia

Article	Year
KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia. The American journal of psychiatry, 2017, 05-01, Volume: 174, Issue:5 Topics: Abnormal Involuntary Movement Scale; Adult; Aged; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mood Disorders; Psychotic Disorders; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Treatment Outcome; Valine	2017
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder. Psychopharmacology bulletin, 2017, 08-01, Volume: 47, Issue:3 Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mood Disorders; Outcome Assessment, Health Care; Psychotic Disorders; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Valine; Vesicular Monoamine Transport Proteins	2017
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder. Psychopharmacology bulletin, 2017, 08-01, Volume: 47, Issue:3 Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Long Term Adverse Effects; Male; Middle Aged; Mood Disorders; Outcome Assessment, Health Care; Psychotic Disorders; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Valine; Vesicular Monoamine Transport Proteins	2017
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder. Psychopharmacology bulletin, 2017, 08-01, Volume: 47, Issue:3 Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Psychotic Disorders; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Valine; Vesicular Monoamine Transport Proteins	2017
Characterizing Treatment Effects of Valbenazine for Tardive Dyskinesia: Additional Results From the KINECT 3 Study. The Journal of clinical psychiatry, 2018, 12-18, Volume: 80, Issue:1 Topics: Adrenergic Uptake Inhibitors; Affective Disorders, Psychotic; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Least-Squares Analysis; Outcome Assessment, Health Care; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Valine	2018
Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference. Movement disorders : official journal of the Movement Disorder Society, 2019, Volume: 34, Issue:8 Topics: Aged; Antipsychotic Agents; Female; Humans; Male; Middle Aged; Minimal Clinically Important Difference; Mood Disorders; Psychotic Disorders; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Treatment Outcome; Valine; Vesicular Monoamine Transport Proteins	2019
Tetrabenazine augmentation in treatment-resistant schizophrenia: a 12-week, double-blind, placebo-controlled trial. Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:1 Topics: Adrenergic Uptake Inhibitors; Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Clozapine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology; Tetrabenazine	2012
Placebo response in refractory tardive akathisia. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1993, Volume: 38, Issue:4 Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Diazepam; Double-Blind Method; Humans; Male; Middle Aged; Neurologic Examination; Placebo Effect; Propranolol; Schizophrenia; Schizophrenic Psychology; Tetrabenazine	1993

Other Studies

20 other study(ies) available for tetrabenazine and Schizophrenia

Article	Year
[Late-Onset Dyskinesia Occurring During Antipsychotic Treatment for Schizophrenia: Treatments for Tardive Dyskinesia]. Brain and nerve = Shinkei kenkyu no shinpo, 2022, Volume: 74, Issue:5 Topics: Antipsychotic Agents; Dopamine Antagonists; Humans; Schizophrenia; Tardive Dyskinesia; Tetrabenazine	2022
[Late-Onset Dyskinesia Occurring During Antipsychotic Treatment for Schizophrenia: Management of Tardive Dyskinesia Based on the Latest Knowledge]. Brain and nerve = Shinkei kenkyu no shinpo, 2022, Volume: 74, Issue:5 Topics: Antipsychotic Agents; Dyskinesias; Humans; Schizophrenia; Tardive Dyskinesia; Tetrabenazine	2022
Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia. The Journal of clinical psychiatry, 2020, Jan-28, Volume: 81, Issue:1 Topics: Antipsychotic Agents; Diagnosis, Differential; Drug Monitoring; Early Diagnosis; Humans; Membrane Transport Modulators; Mood Disorders; Patient Care; Patient Education as Topic; Psychology; Risk Assessment; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Valine	2020
Revisiting Tardive Dyskinesia: Focusing on the Basics of Identification and Treatment. The Journal of clinical psychiatry, 2020, 02-18, Volume: 81, Issue:2 Topics: Adrenergic Uptake Inhibitors; Adult; Antipsychotic Agents; Diagnosis, Differential; Dopamine Antagonists; Female; Humans; Male; Middle Aged; Schizophrenia; Tardive Dyskinesia; Tetrabenazine; Valine; Vesicular Monoamine Transport Proteins	2020
Increased platelet vesicular monoamine transporter density in adult schizophrenia patients. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2002, Volume: 12, Issue:4 Topics: Adult; Binding, Competitive; Blood Platelets; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Neuropeptides; Protein Binding; Schizophrenia; Tetrabenazine; Tritium; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins	2002
A comparison of tetrabenazine and chlorpromazine in chronic schizophrenia. The Journal of mental science, 1961, Volume: 107 Topics: Chlorpromazine; Schizophrenia; Tetrabenazine; Tranquilizing Agents	1961
[Report on experiences with the use of "Nitoman"]. Psychiatria et neurologia, 1960, Volume: 140 Topics: Schizophrenia; Tetrabenazine; Tranquilizing Agents	1960
Clinical comparison of tetrabenazine (Ro 1-9569), reserpine and placebo in chronic schizophrenics. Diseases of the nervous system, 1960, Volume: 21(3)Suppl Topics: Hypnotics and Sedatives; Reserpine; Schizophrenia; Tetrabenazine	1960
TETRABENAZINE (NITOMAN) IN THE TREATMENT OF PSYCHOSES. WITH A DISCUSSION ON THE CENTRAL MODE OF ACTION OF TETRABENAZINE AND RESERPINE. Acta psychiatrica Scandinavica, 1963, Volume: 39 Topics: Behavior, Animal; Brain; Chemical Phenomena; Chemistry; Humans; Metabolism; Norepinephrine; Pharmacology; Placebos; Prognosis; Psychotic Disorders; Rats; Research; Reserpine; Schizophrenia; Serotonin; Tetrabenazine; Toxicology	1963
A STUDY OF THE BEHAVIOR AND EEG PATTERNS OF PATIENTS RECEIVING TRANQUILIZERS WITH AND WITHOUT THE ADDITION OF CHLORDIAZEPOXIDE. Journal of neuropsychiatry, 1964, Volume: 5 Topics: Bipolar Disorder; Chlordiazepoxide; Drug Synergism; Drug Therapy; Electroencephalography; Fluphenazine; Humans; Pharmacology; Phenobarbital; Psychotic Disorders; Schizophrenia; Tetrabenazine; Thioridazine; Tranquilizing Agents	1964
Neurotransmitter depleter tetrabenazine; potential candidate for schizophrenia treatment? Schizophrenia research, 2007, Volume: 96, Issue:1-3 Topics: Adrenergic Uptake Inhibitors; Clinical Trials as Topic; Humans; Schizophrenia; Tetrabenazine	2007
Olanzapine-induced tardive dystonia successfully treated by tetrabenazine. The Journal of neuropsychiatry and clinical neurosciences, 2007,Fall, Volume: 19, Issue:4 Topics: Anti-Dyskinesia Agents; Antipsychotic Agents; Benzodiazepines; Dyskinesia, Drug-Induced; Humans; Male; Middle Aged; Olanzapine; Schizophrenia; Tetrabenazine	2007
[Therapy of schizophrenia with tetrabenazine]. Nihon rinsho. Japanese journal of clinical medicine, 1966, Volume: 24, Issue:7 Topics: Adolescent; Adult; Child; Female; Humans; Male; Middle Aged; Schizophrenia; Tetrabenazine	1966
Tardive dyskinesia. Neurologic clinics, 1984, Volume: 2, Issue:3 Topics: Antipsychotic Agents; Diagnosis, Differential; Dyskinesia, Drug-Induced; Humans; Reserpine; Schizophrenia; Tetrabenazine; Thioridazine	1984
Atypical variants of tardive dyskinesia, treated by a combination of clozapine with propranolol and clozapine with tetrabenazine. The Journal of nervous and mental disease, 1993, Volume: 181, Issue:10 Topics: Adult; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Propranolol; Schizophrenia; Tetrabenazine	1993
[Torticollis spasmodicus as a manifestation of tardive dystonia]. Fortschritte der Neurologie-Psychiatrie, 1995, Volume: 63, Issue:10 Topics: Anti-Dyskinesia Agents; Antipsychotic Agents; Biperiden; Diagnosis, Differential; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Neurologic Examination; Schizophrenia; Tetrabenazine; Torticollis	1995
Tardive tremor. Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:5 Topics: Anti-Dyskinesia Agents; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Motor Activity; Posture; Rest; Schizophrenia; Tetrabenazine; Tremor	1997
In vivo measurement of the vesicular monoamine transporter in schizophrenia. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2000, Volume: 23, Issue:6 Topics: Adolescent; Adult; Binding Sites; Carbon Radioisotopes; Disease Progression; Dopamine; Female; Humans; Image Processing, Computer-Assisted; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Neostriatum; Neuropeptides; Presynaptic Terminals; Radioligand Assay; Schizophrenia; Synaptic Vesicles; Tetrabenazine; Tomography, Emission-Computed; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins	2000
Tardive dyskinesia. Lancet (London, England), 1979, Sep-01, Volume: 2, Issue:8140 Topics: Antipsychotic Agents; Baclofen; Benzodiazepines; Choline; Dyskinesia, Drug-Induced; Humans; Pimozide; Receptors, Dopamine; Schizophrenia; Tetrabenazine	1979
[The pharmacologic properties and therapeutic effectiveness of the new antidepressant preparation Azaphen]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1969, Volume: 69, Issue:8 Topics: Adult; Aged; Amphetamine; Animals; Antidepressive Agents; Bipolar Disorder; Cats; Depression; Depressive Disorder, Major; Dogs; Drug Synergism; Humans; Male; Mice; Middle Aged; Neurocognitive Disorders; Rats; Reserpine; Schizophrenia; Tetrabenazine	1969